CYTOO is a leading biotechnology company based in Framingham, MA, specializing in the development and screening of innovative cellular models and assays for various physiological applications. Their cutting-edge technology allows for the restoration of mature phenotypes in cells, enabling high-content screening with multiplexed visual read-outs and high throughput. With a focus on areas such as muscular atrophy, hypertrophy, and drug profiling, CYTOO offers a range of products including chips, plates, and accessories to support their advanced cellular models.
Driven by a commitment to scientific excellence, CYTOO has gained recognition for their groundbreaking work in fields like cardiomyocytes, oncospheres, myoscreen, and renal proximal tubules. Their expertise in creating physiologically relevant cellular models has attracted collaborations with renowned partners and participation in prestigious events. As they continue to explore the impact of dysregulated metabolism on muscle physiology, CYTOO remains at the forefront of innovation in the biotechnology industry.
Generated from the website